Strategies to uncover undiagnosed HIV infection among heterosexuals at high risk and link them to HIV care with high retention: a “seek, test, treat, and retain” study by unknown
Gwadz et al. BMC Public Health  (2015) 15:481 
DOI 10.1186/s12889-015-1816-0STUDY PROTOCOL Open AccessStrategies to uncover undiagnosed HIV infection
among heterosexuals at high risk and link them
to HIV care with high retention: a “seek, test,
treat, and retain” study
Marya Gwadz1*, Charles M. Cleland1, Holly Hagan1, Samuel Jenness2, Alexandra Kutnick1, Noelle R. Leonard1,
Elizabeth Applegate1, Amanda S. Ritchie1, Angela Banfield1, Mindy Belkin1, Bridget Cross1, Montserrat Del Olmo1,
Katharine Ha1, Belkis Y. Martinez1, Talaya McCright-Gill1, Quentin L. Swain1, David C. Perlman3, Ann E. Kurth1
and the BCAP Collaborative Research TeamAbstract
Background: Over 50,000 individuals become infected with HIV annually in the U.S., and over a quarter of HIV
infected individuals are heterosexuals. Undiagnosed HIV infection, as well as a lack of retention in care among
those diagnosed, are both primary factors contributing to ongoing HIV incidence. Further, there are racial/ethnic
disparities in undiagnosed HIV and engagement in care, with African Americans/Blacks and Latinos remaining
undiagnosed longer and less engaged in care than Whites, signaling the need for culturally targeted intervention
approaches to seek and test those with undiagnosed HIV infection, and link them to care with high retention.
Methods/Design: The study has two components: one to seek out and test heterosexuals at high risk for HIV
infection, and another to link those found infected to HIV care with high retention. We will recruit sexually active
African American/Black and Latino adults who have opposite sex partners, negative or unknown HIV status, and
reside in locations with high poverty and HIV prevalence. The “Seek and Test” component will compare the
efficacy and cost effectiveness of two strategies to uncover undiagnosed HIV infection: venue-based sampling
and respondent-driven sampling (RDS). Among those recruited by RDS and found to have HIV infection, a “Treat
and Retain” component will assess the efficacy of a peer-driven intervention compared to a control arm with
respect to time to an HIV care appointment and health indicators using a cluster randomized controlled trial
design to minimize contamination. RDS initial seeds will be randomly assigned to the intervention or control arm
at a 1:1 ratio and all recruits will be assigned to the same arm as the recruiter. Participants will be followed for
12 months with outcomes assessed using medical records and biomarkers, such as HIV viral load.
Discussion: Heterosexuals do not test for HIV as frequently as and are diagnosed later than other risk groups. The
study has the potential to contribute an efficient, innovative, and sustainable multi-level recruitment approach and
intervention to the HIV prevention portfolio. Because the majority of heterosexuals at high risk are African American/
Black or Latino, the study has great potential to reduce racial/ethnic disparities in HIV/AIDS.
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Despite advances in antiretroviral treatment, prevention
strategies, and HIV diagnostic testing technologies, HIV
disease incidence in the United States has remained
steady, with over 50,000 individuals becoming infected
annually [1]. Undiagnosed HIV infection is a major
driver of these incident infections, although only 18 % of
infected persons nationally are unaware of their HIV sta-
tus [2–4]. In fact, 44 to 66 % of new HIV infections are
attributed to this modest proportion of individuals with
undiagnosed HIV [3, 5]. Moreover, there are serious ra-
cial/ethnic disparities in undiagnosed HIV, with African
Americans/Blacks and Latinos remaining undiagnosed
longer than Whites [6]. Further, undiagnosed HIV is
more common in males compared to females, and
among heterosexual males compared to men who have
sex with men (MSM) [6]. (Acronyms used in this proto-
col description are defined in Table 1.)
In 2010, the National Institute on Drug Abuse
(NIDA) at the National Institutes of Health called for
research on new approaches to seek out persons with
undiagnosed HIV, provide them with counseling and
testing, and link those found to be HIV infected into
medical care, with high retention, which are referred to
as “Seek, Test, Treat, and Retain” (STTR) studies. This
paper summarizes the study protocol for our STTR
study funded under this initiative, which is being
conducted in the borough of Brooklyn in New York
City, called the “Brooklyn Community Action Project”
(BCAP).
High-risk heterosexuals in the U.S
The National HIV Behavioral Surveillance (NHBS) system
estimates the prevalence of HIV infection in three high-Table 1 Acronyms used
ACASI Audio Computer-Assisted Interviewing format
ART Antiretroviral therapy
BCAP Brooklyn Community Action Project
CDC Centers for Disease Control and Prevention
HHR Heterosexuals at high risk (for HIV)
HRA High-risk area
MSM Men who have sex with men
NHBS National HIV Behavioral Surveillance
PDI Peer-driven intervention
PWID Persons who inject drugs
RDS Respondent-driven sampling
STTR Seek, Test, Treat and Retain
VBS Venue-based sampling
VDT Venue, day-time unitsrisk populations on a rotating basis in 20 Metropolitan
Statistical Areas across the U.S.: heterosexuals at high risk
(HHR), men who have sex with men (MSM), and persons
who inject drugs (PWID). The NHBS studies use two
main sampling frames across study locations, as deter-
mined by the CDC: venue-based sampling (VBS), gen-
erally used for the MSM studies, and respondent-driven
sampling (RDS), used to enroll PWID and HHR [7].
However, VBS and RDS have never been directly com-
pared in the same Metropolitan Statistical Area in
terms of recruiting populations who may benefit from
STTR interventions.
Nationally, over 25 % of incident HIV infections have
been attributed to heterosexual activity [8]. In 2010, the
national NHBS with HHR found an estimated HIV
prevalence of 2.3 % [8]. The NHBS study design for
HHR targets adults who are sexually active with opposite
sex partners and who are socially and geographically
connected to areas with high HIV prevalence, which also
happen to be high-poverty areas, in which African
American/Black and Latino persons are the predominant
race/ethnicity [9, 10]. Indeed, the HIV disease burden in
these communities is much higher in these geographical
areas than across the U.S. generally, where the overall
HIV prevalence is estimated at 0.6 % [11]. Locally, in the
2006 New York City NHBS study of HHR, for which de-
tailed data have been published, HIV prevalence was
8.6 %, with an estimated HIV incidence in this popula-
tion of 3.31 % per year and 2.59 % per year among those
with no history of drug injection or male-to-male sex
[12]. Further, Brooklyn had the highest HIV prevalence
and the highest rates of risk factors (unpublished obser-
vations, Holly Hagan, 2010), and is therefore the geo-
graphic focus of the present study.
Yet HHR are understudied relative to other HIV risk
groups [13]. One difficulty in establishing research prior-
ities for HHR has been the lack of a universal definition
of the population. Heterosexual activity alone is overly
broad to define a high-risk subgroup, while the CDC
surveillance definition of documented heterosexual con-
tact with someone known to be HIV-infected is too nar-
row [1, 12]. The NHBS definition of HHR is persons
with sexual partners of the opposite sex linked within
urban geographical areas with high rates of heterosexually
transmitted HIV, which also have high rates of poverty
[14]; these geographical locations are called “high-risk
areas” (HRAs). Due to the marked over-representation of
African American/Black and Latino populations in these
high prevalence/high-poverty neighborhoods, the majority
of HHR are from these two racial/ethnic groups [9]. Thus
the CDC has called for research to test culturally appro-
priate interventions to overcome barriers to HIV testing
and increase linkage to HIV care for heterosexuals in
high-risk urban areas [8].
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Diagnostic HIV testing is critical to HIV prevention, and
the CDC recommends annual testing for vulnerable
populations such as HHR [14]. Yet rates of regular HIV
testing are inadequate in this group, and as a result, late
diagnosis of HIV is common [15, 16]. A recent local
NHBS study found that while over 90 % of HHR had en-
countered at least one setting where HIV testing is of-
fered in the past year, only a third had actually been
tested, suggesting that HHR often decline testing when
it is offered [15]. Moreover, vulnerable subgroups of
HHR encounter settings where testing is offered infre-
quently [17]. Thus culturally acceptable and efficient ac-
tive approaches to seek out HHR and engage them in
high-quality HIV testing are needed.
Post diagnosis, there are a number of serious gaps in
HIV care engagement, and clinical and health outcomes
[18, 19]. Of the 1.1 million Americans living with HIV,
60 % are not retained in care; 63 % have not been pre-
scribed antiretroviral therapy (ART); and only 30 % have
undetectable HIV viral load levels, the latter being the
ultimate goal of HIV treatment [20]. The CDC has called
for improvement in outcomes across this HIV care con-
tinuum, with particular efforts to reduce racial/ethnic dis-
parities [21], since African Americans/Blacks and Latinos
show lower rates of engagement in every indicator. More-
over, by risk group, HHR may experience longer delays
before entering HIV care compared to MSM.
Barriers to HIV testing and timely engagement in
HIV care for HHR
In our study, we conceptualized the multi-level barriers
that African American/Black and Latino HHR experi-
ence to HIV testing and engagement in HIV care within
the Theory of Triadic Influence [22]. This social cogni-
tive theory emphasizes three “streams of influence” on
health behavior: the individual/attitudinal, the social, and
the structural.
At the individual/attitudinal level of influence, barriers
to testing for HHR include lack of awareness of recom-
mended testing frequency, and low perceived risk of
HIV infection stemming from beliefs that HIV affects
mainly PWID and MSM [23, 24]. At the same time, fear
of HIV testing and of the consequences of a positive test
result are common powerful barriers [25, 26], along with
mistrust of medical environments [25]. Substance use,
which is common among HHR, has also been shown to
serve as a barrier [25, 27]. Moreover, the population has
other competing priorities, complicated by low socioeco-
nomic status, such as mental health problems, unstable
housing, and family and child-care responsibilities [17,
23]. At the social level, the potential stigma of a positive
test result serves as a barrier to HIV testing [28]. Peer
norms regarding health care, including that regular HIVtesting is not necessary for HHR, may impede testing
[29]. At the structural level, HHR have poorer access to
settings where high-quality HIV testing is offered [15,
30]. Theoretically, barriers at these three levels of influ-
ence interact to impede access to HIV testing and
reduce motivation to test among HHR. Furthermore,
this same set of barriers also impedes linkage to and re-
tention in HIV primary care among HHR diagnosed
with HIV [31–33]. The present protocol describes two
culturally targeted STTR intervention strategies for
HHR to reduce these barriers to HIV testing and timely
engagement in HIV care.
Peer-driven intervention and respondent-driven
sampling
Our study features a peer-driven intervention (PDI), in
which participants are educated by peers on a set of core
messages, then engage in structured facilitated sessions,
followed by the opportunity to educate their own peers
[34, 35]. The core messages target the specific barriers
to the health outcome of interest - HIV testing and
engagement in HIV care in this case - and are repeated
and expanded upon throughout the intervention activ-
ities. Peers who receive the education from study partici-
pants are also invited to join the research study, and
during the course of the intervention, they are trained to
educate their own peers. (The BCAP intervention man-
ual is available from the first author).
Because PDI involves peer-to-peer contact, it can serve
as the basis for a sampling methodology for studying sub-
populations that are hard to define, reach, and/or engage:
respondent-driven sampling (RDS). RDS is network-based
method for recruitment, similar to traditional snowball
sampling, but with the goal of minimizing biases typically
associated with those traditional methods [36, 37]. In RDS,
a modest number of individuals are recruited directly by
project staff (called “initial seeds”), and then trained to re-
cruit a small number of their peers into the study. These
peers then enter the study and peer recruitment continues
until the sample size goals are met [36, 38]. The RDS
method has four essential elements: tracking of recruit-
ment chains; rationing of recruitment (usually 2-5 peers
each); information on personal networks must be gathered
(network size, recruitment refusals); and recruiters and re-
cruits must have a pre-existing relationship [39].
Aims
The present study has two phases, a Seek and Test
Phase and a Treat and Retain Phase. As shown in Fig. 1,
the PDI/RDS study component includes activities to seek
out and test HHR and strategies to link those found to
be HIV-infected to medical care in a timely fashion.
However, by design, we do not hypothesize differences
in acceptance of HIV testing, which is > 90 % in similar
Fig. 1 Two-phase BCAP PDI/RDS Model
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undiagnosed HIV between intervention and control
arms, although these will be documented in the Seek
and Test Phase. Thus the main aim of the study is to
measure the efficacy of the BCAP PDI compared to a
time- and attention-matched control intervention on the
second-phase Treat and Retain outcomes, including 1)
time to an HIV clinic appointment; 2) time to initiating
ART if indicated; 3) HIV viral load suppression; and 4)
retention in care among the newly diagnosed. These out-
comes are assessed with serology (viral load suppression)
and medical record abstraction. We hypothesize the PDI
arm, compared to the control arm, will produce a
shorter time to care entry and ART initiation, higher
viral load suppression, and superior retention in care.
The study also will project the clinical impact, costs, and
cost-effectiveness of these two strategies (PDI vs. con-
trol) for care linkage and retention. Thus although the
Seek and Test Phase temporally precedes the Treat and
Retain Phase, we begin by describing the Treat and
Retain phase, because it is the primary focus of the
present study.
Part 1: Treat and retain phase
Methods
Study setting
In the planning stage of the study in 2011, a core high-risk
area (HRA) was defined within Brooklyn, the borough in
New York City with the highest heterosexual HIV preva-
lence in the 2006 NHBS study, which were the most up-
to-date available NHBS data at the time. The classification
of the HRA was based on the definition created in theNHBS studies in 2006, namely, a small set of zip codes
with both the highest prevalence of poverty and rates of
heterosexual HIV [14, 15]. We selected a new HRA cluster
for the present study using updated HIV surveillance and
2011 demographic data, based on the approach described
in the next section [42].
HRA index
Two inputs were obtained for all of the 52 Brooklyn zip
codes: 1) the percent of households in poverty, based on
2009 projections from U.S. Census [43]; and 2) the num-
ber of HIV diagnoses from 2005 to 2009, from New York
City Department of Health and Mental Hygiene case sur-
veillance data [44]. For each zip code in Brooklyn, a
numerical “HRA index” was calculated by standardizing
the poverty and heterosexual HIV prevalence to the over-
all levels in Brooklyn. The HIV prevalence was calculated
based on a denominator of adults in each zip code, assum-
ing the fraction of non-heterosexually active adults was
relatively small and evenly distributed across the geog-
raphy. The final HRA index for each zip code was the sum
of the standardized HIV and poverty scores.
Selecting the HRA cluster The 52 indexed zip codes
were then geographically mapped to establish a thresh-
old for the final HRA cluster selection. The goal was to
select a set of zip codes based on a high index value that
would form a geographic cluster corresponding to a con-
tiguous set of neighborhoods. This cluster analysis was
completed qualitatively and quantitatively. Qualitative
assessments were made by examining maps with HRA
thresholds from the top 10 to 40 % of index values.
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statistic (Moran’s I) to determine the extent of cluster-
ing, then a locally indicated spatial autocorrelation stat-
istic (LISA Moran’s I) to quantify the location of any
clustering [45]. Based on this analysis, the HRA for the
present study was defined as the top 25 % of the zip
codes (see Fig. 2, the light grey region), a contiguous
block of 7 zip codes that included several neighbor-
hoods in central Brooklyn. We refer to this region as
the “core HRA”. Since HHR move freely across the
boundaries of the core HRA, we also selected a lower
threshold to reduce artificial restriction of RDS recruit-
ment chains. This larger HRA comprised the top 50 %
of the HRA index, corresponding to an additional 11
zip codes (see Fig. 2). The BCAP study field site was lo-
cated in the core HRA, as was recruitment of “initial
seeds” to start the RDS recruitment chains. However,
recruitment of peers could extend to the larger HRA.
Study design using PDI/RDS
As noted above, RDS begins with direct recruitment of
a small number of initial seeds who start recruitmentFig. 2 Core High-risk Area (HRA; in light grey) and surrounding larger HRAchains by recruiting their peers into the research
[36, 38]. In the present study, initial seeds are randomized
to an intervention or control arm at a 1:1 ratio. Further,
eligible and consenting peers who are subsequently
recruited into the study are assigned to the same arm as
their recruiter. Thus each initial seed and the peers
subsequently enrolled in his/her recruitment chain are
considered a cluster. This cluster randomized con-
trolled trial design is necessary because intervention
activities begin at the time of recruitment, when
recruiters educate peer recruits on core messages. Be-
cause the statistical power of a clustered trial increases
with the number of clusters, we plan to recruit more
seeds than is typical in RDS (namely 40 seeds per arm),
with a target sample size of 3000 individuals. The PDI/
RDS study component also includes those with previ-
ously diagnosed infection (called “known positives”),
and will describe HIV health indicators and engage-
ment in HIV care among this subgroup. Study activities
are approved by the Institutional Review Board at the
NYU School of Medicine, and the protocol is registered
with clinicaltrials.gov (NCT01607541).(dark grey), in the borough of Brooklyn
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A list of random allocations for initial seed participants
is generated by the study statistician in randomly or-
dered permuted blocks of 2, 4, 6, 8, or 12 allocations.
The allocation list is stored in a password-protected file
that can only be accessed by the study statistician, data
manager, and project director. None of these individuals
are responsible for consent, enrollment, or delivery of
intervention content to participants. After informed con-
sent is obtained, field staff will contact the statistician,
data manager, or project director by phone for an alloca-
tion for each initial seed. During this phone call, the
statistician, data manager, or project director records the
unique identification number of the initial seed and the
date on the allocation list, and then relays the assigned
study arm to staff in the field.
The BCAP PDI
Motivational Interviewing is the intervention’s main coun-
seling approach. Motivational Interviewing is a flexible,
collaborative counseling method that actively engages, fo-
cuses, and guides participants, without judgment or pres-
sure, in order to elicit and strengthen durable, high quality
intrinsic motivation for behavior change [46]. The BCAP
PDI is culturally targeted to address the main barriers that
African American/Black and Latino HHR experience to
HIV testing and linkage to HIV care. The BCAP PDI is
strengths-based, drawing on empowerment messages
highlighting community mobilization against HIV.
The PDI approach taps into six critical elements of be-
havior change: knowledge, skill building, motivation,
peer influence, social norms, and repetition [34, 47, 48].
When used with vulnerable populations, PDI capitalizes
on the personal and community-minded transformative
changes that often occur among such groups [49–52].
PDI is based on the Theory of Normative Regulation,
which posits that the behaviors of individuals are shaped
by social norms and amplified through their social
groups [36]. When individuals appeal to peers’ behavior
(e.g., HIV testing), their own behavioral commitments
may be strengthened. Messages delivered by peers can
be potent because peers can have more credibility than
professionals [27, 53]. PDI is also cost-efficient, with
much of the intervention conducted by participants.
Eligibility criteria and screening for eligibility
Study eligibility criteria are the same for initial seeds and
peers with two exceptions. Study eligibility criteria are:
age 18-60 years; sexually active (vaginal and/or anal sex)
with at least one opposite sex partner within the previ-
ous year; reside in the larger HRA (but initial seeds must
reside only in the core HRA); African American/Black
or Latino/Hispanic race/ethnicity; comprehension of
English or Spanish; unknown HIV status (for initial seedsonly; peers may report previous HIV diagnosis); not ac-
tively psychotic; not a participant in the past local NHBS
studies with HHR.
Peers present to the study with a coded recruitment
coupon linking the recruiter to the recruit. Consenting
recruits participate in a brief computerized screening
interview to determine eligibility, including questions
about their relationship with the recruiter. All screened
participants are provided an incentive ($15) and re-
cruiters are also compensated for each peer who pre-
sents to the study depending on peer eligibility ($5-25).
Initial seeds are directly recruited by staff, as noted
above, and are screened for eligibility using these same
procedures. The next section describes procedures for
participants who are HIV negative or do not know their
HIV status at the time of screening, the main focus of
the study, followed by a brief description of activities for
those who enter the study with known HIV infection.
BCAP PDI study activities
Seek and test activities
Peer education For those in the intervention arm, the
BCAP PDI begins when potential participants receive peer
education on a small number of core messages from a
study participant, along with a coded recruitment coupon.
(See Fig. 3 for the sequence of intervention and assess-
ment activities for the BCAP PDI intervention arm. Note
that we show activities for both the Seek and Test and
Treat and Retain phases in this figure for clarity, and be-
cause the Seek and Test activities create the basis for those
conducted in the Treat and Retain phase.)
Baseline assessment Participants complete a structured
baseline interview administered via the Audio Computer-
Assisted Interviewing format (ACASI) lasting 60-90 min.
The baseline interview assesses socio-demographics,
health, substance use, sexual behavior, HIV testing history,
and peers’ experiences with HIV testing and risk behav-
iors. Baseline interviews mainly assessed the lifetime and
past 6-month period and the battery is comprised mainly
of a set of harmonized measures developed for the set of
NIDA-funded STTR projects [54].
Introductory intervention session #1 Participants en-
gage in an intervention session individually with a trained
interventionist lasting 20-60 min, usually within two
weeks. The goals of the session are to engage the partici-
pant and motivate him/her to conduct peer recruitment/
education and continue in the study. Control arm partici-
pants are taught how to recruit peers for the study during
this session, and intervention arm participants are also
taught and motivated to educate their peers on the core
messages during the course of recruitment. Participants
Fig. 3 Schematic Representation of PDI/RDS and assessment sequence
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used for a female participant, as a “steering incentive” [55].
Recruitment period Participants enter a two-week
period where they may recruit and educate a small number
of peers and provide them with recruitment coupons.
Those peers then contact the study directly to be screened,
and the participant continues in the study. Participants
may decline to recruit peers and continue in the study.
Intervention session #2 Participants return for a sec-
ond one-on-one intervention session two weeks after
their initial session. During this session, CDC required pre-
test counseling is provided to assess readiness and desire
for testing. If participants decide to test, standard consent
is obtained, followed by the OraQuick Advance Rapid
HIV-1/2 Antibody Test with oral mucosal fluid. While the
test is processing, subjects complete a computerized HIVprevention and risk-reduction program, called CARE for
Prevention [56]. If the rapid HIV test is non-reactive,
participants are counseled and provided referrals, and their
involvement in the study is complete.
For reactive tests, a second OraQuick Advance Rapid
HIV test is administered, similar to local health department
protocols, to minimize false positive results on site [57].
An OraSure Western Blot confirmatory test is also con-
ducted, with results available in 1-2 weeks. Participants are
then asked to provide blood specimens for HIV viral load
and CD4 testing. Because some newly diagnosed partici-
pants decline to provide blood at diagnosis, they may do so
at a future contact if they so choose. Navigation (described
below) may begin at this point for intervention arm partici-
pants who have serious barriers to engaging in future study
activities, including meeting to receive confirmatory
results, or the session may end after the blood specimen is
provided and navigation may begin at Session 3.
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are provided confirmatory test results and post-test coun-
seling following CDC and local guidelines. Those in the
control arm receive standard post-test counseling with re-
ferral to HIV health care and up to three phone reminders
to attend the appointment. For intervention-arm partici-
pants, the session then turns to a discussion of the naviga-
tion component of the BCAP PDI. Participants receive
compensation for each session ($30) and blood draws
($25), plus local round-trip public transportation.
Treat and retain phase activities
Navigation Navigation is a flexible and individualized
intervention approach to reduce disparities in care for low
income or marginalized populations [58, 59]. In practice,
navigation identifies and resolves the organizational, social,
and individual barriers patients may experience to acces-
sing these services [60]. In the BCAP PDI, navigation uses
a strengths-based approach that draws on Motivational
Interviewing techniques, guided by an Action Plan that is
revisited over time. The aim of the Action Plan is to iden-
tify and resolve barriers to linkage to HIV care and sup-
port engagement in care. If there are no major barriers to
care, the navigator can monitor and support engagement
in care. If there are barriers (e.g., mental illness or sub-
stance abuse), navigation involves several options: com-
munication with the primary care provider; screening and
“fast track” referrals for substance use, mental illness,
housing and other services; accompaniment to health care
appointments; phone call reminders; and in-person meet-
ings to support adaptation to the HIV diagnosis and link-
age to care. Contacts are documented, and participants
receive modest financial incentives for the first four navi-
gation meetings to establish the working alliance during
this critical period ($10 each).
Aspects of the PDI and assessments
Differences between the BCAP PDI and control arm
Intervention arm participants 1) receive peer education
at the time of recruitment, which introduces them to the
core messages, while controls do not receive peer educa-
tion; 2) are trained to educate their own peers on the
core messages that reinforce the core messages, while
controls are trained only to recruit peers; and 3) the
newly diagnosed receive patient navigation while con-
trols receive treatment as usual (an HIV care appoint-
ment and follow-up phone calls), as shown in Fig. 1.
Network-based case finding To increase access to the
undiagnosed, participants who are newly diagnosed with
HIV during the study are given the opportunity to re-
cruit three additional peers, and encouraged to recruit
sexual or injection drug-sharing partners if they choose.
This is a form of network-based case finding [61, 62].The newly diagnosed participant’s recruiter also receives
coupons, as does one participant randomly selected from
the same arm. This latter strategy is designed to protect
the newly diagnosed participant’s confidentiality, as well
as that of his/her recruiter, by masking the reason for re-
ceiving additional coupons.
Follow-up assessments Participants in both arms are
assessed at four time points: at Session 3, the time of
diagnosis (the Time 2 [T2] assessment), and 3- (T3), 6-
(T4), and 12-months post-baseline (T5). The T2, T3, and
T4 interviews assess the prior quarter, and the T5 inter-
view (12-month follow-up) assesses the prior 6 month
period. The assessment includes measures on care engage-
ment, satisfaction, understanding of HIV, and HIV medica-
tions prescribed, side effects, and adherence [63–65]. All
assessments are conducted using ACASI and take approxi-
mately an hour. At T5, blood is drawn to measure CD4
count and HIV viral load; a Medical Report Form contain-
ing data on attendance at care appointments over the past
year drawn from the medical record is also completed.
Participants receive modest compensation for assessment
activities ($25-$30).
Activities for those with previously diagnosed HIV infection
at screening (“known positives”)
Participants with previous HIV diagnoses are hypothe-
sized to be an important means of finding the undiag-
nosed [66]. Yet they also may be poorly engaged in HIV
care, thereby in need of intervention. As noted in the
section on Eligibility Criteria, the PDI/RDS study enrolls
peers (but not initial seeds) with previously diagnosed
HIV infection. At screening, the peer’s HIV status is con-
firmed with medical documentation. A baseline interview
assesses the domains noted above, supplemented with
data on HIV health status, engagement in care, experience
with providers, and ART prescription and adherence [67].
Participants then engage in a single intervention session
and are trained to recruit/educate (intervention arm) or
recruit (control arm) peers, and their past-year HIV health
care attendance patterns and satisfaction with care are
evaluated to determine whether navigation to HIV care is
required. Participants then have the opportunity to recruit
3-5 peers over a two-week period, and navigation to care
is provided. At four months post baseline, a Medical Re-
port Form capturing CD4, HIV viral load, and health care
attendance over the past year from the medical record is
completed.
Changes to procedures during implementation
Complex research studies often undergo refinements in
their early stages. A number of changes were made to the
initial study protocol over the first six months of imple-
mentation in response to high rates of ineligibility (> 40 %),
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chains, low numbers of female participants, an imbalance
between intervention and control arms, and low rates of
HIV-infected participants in the study’s early phase of
implementation. These study inefficiencies were reviewed
by the study Principal and Co-Investigators, who made rec-
ommendations for adjustments. In response, changes to
some eligibility criteria were instituted. Initially, partici-
pants were eligible if they had not been tested for HIV in
the past year; were HIV negative or unknown status; were
aged 18-50 years; and resided only in the core seven zip
code HRA. Further, there was initially no steering incentive
for women. Third, the control intervention Session 1 was
very brief (~5-10 min to orient participants and train them
how to recruit peers, which was not sufficient for engage-
ment). The changes to eligibility criteria reflected in the
section above were designed to reduce ineligibility and im-
prove study efficiency; steering incentives to boost the pro-
portion of women in the sample; and increasing the
duration of the control Session 1 is intended to improve
engagement among the control arm participants. The final
protocol described above will be implemented for > 75 %
of the sample.
Data analysis
The hypothesis for the main Treat and Retain aim is that
compared with participants in the control arm, PDI arm
participants will be more likely to 1) attend an HIV clinic
appointment sooner; 2) initiate ART earlier; 3) achieve
viral load suppression; and 4) be retained in HIV care dur-
ing the 12-month follow-up period. Logistic regression
will be used to compare groups on viral load suppression.
Since HIV viral load assay results range from <50
to >100,000 copies/ml, other generalized linear models
will examine intervention impact on median viral load, log
transformed viral load, and on viral load dichotomized at
1,000 or 10,000 copies/ml, which have been associated
with greater HIV transmission risk [68–71]. Cox propor-
tional hazards regression will compare groups on time to
first HIV clinic appointment and initiation of ART if indi-
cated. Frailty models [72, 73] will examine intervention
effects on first HIV clinic appointment and initiation of
ART with participants clustered by recruitment chain.
Covariates for these analyses will include prior HIV testing
and initial viral load.
Power analysis
We estimate 10 % of all participants will be newly diag-
nosed with HIV infection and assume an attrition rate of
15 % at the last follow-up among those with newly diag-
nosed HIV infection (N = 254). We estimate the smallest
detectable difference in proportion between PDI and
control arms given a desired power of 80 % and α = .05.
Assuming 15-45% of control participants achieve HIVviral load suppression within 12 months, odds ratio of
2.07 are detectable. With an ICC as high as .20 due to
clustering by 80 seeds, the effective sample size is n = 176
and odds ratios of 2.39 are detectable.
Part 2: Seek and test phase
Introduction
Study aims
The aim of the Seek and Test Phase is to compare the
relative yield and efficiency of RDS, described above, and
venue-based sampling (VBS) to seek out and identify pre-
viously undiagnosed HIV infection among HHR, and to
project the clinical impact, costs, and cost-effectiveness of
these two strategies (as shown on Fig. 4). Although the
NHBS uses both VBS and RDS methods, they have not yet
been directly compared in terms of their efficacy and cost-
effectiveness to identify undiagnosed HIV among HHR in
the U. S. The present study addresses this gap in the litera-
ture by conducting VBS and RDS in the same geograph-
ical location, namely, the core HRA, and targeting the
same underlying population of HHR.
Venue-based sampling (VBS)
VBS is a method to systematically recruit individuals in
a target population who may be hard-to-reach, but who
may be located and engaged in identifiable venues such
as parks and hair salons. VBS has proven successful in
identifying populations at high risk of HIV infection,
mainly MSM [74–76], but also heterosexuals in the U.S.
and globally [77, 78]. VBS starts by identifying days and
times at which the target population gathers at specific
venues, constructing a sampling frame of venue-day-
time units (VDTs), randomly selecting and visiting VDTs
(the primary sampling units), and systematically inter-
cepting and collecting information from consenting
members of the target population [74].
Hypotheses and endpoints
We hypothesize a higher proportion of newly diagnosed
participants will be recruited by RDS than VBS, after con-
trolling for socio-demographic differences between the
samples. This is because RDS is designed to reach deep into
hidden or wary populations, engaging the more isolated or
vulnerable network members who may not be present in
social venues [61]. Indeed, peers have credibility that can
foster engagement with research studies more effectively
than direct recruitment by research staff, even for those
with multiple barriers to HIV testing [62].
Methods
Defining and identifying specific venues within the HRA
Once the core HRA had been defined, as we described
above, we identified venues within it to establish the
locations and times for sampling. A venue is defined as a
Fig. 4 Seek and Test Phase
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lation may congregate or pass through [76]. Typically VBS
studies target discrete venues such as churches, hair salons
and barbershops, recreational centers, bars, city parks,
parks or street corners outside public housing facilities,
and grocery stores [76]. While members of the target
population naturally congregate in these locations, these
types of venues may require the permission of a manager
or other gatekeeper before recruitment. Indeed, parks and
public housing are regulated by the local authorities, and
private venues can close during the study period. Thus tar-
geting these types of venues is labor-intensive.
However, the population density, built environment, and
population transportation dynamics of central Brooklyn
suggested an alternate means of defining a venue, namely,
as city blocks where the target population congregates orpasses through. But since central Brooklyn is geographically
large (70.82 sq. miles) and densely populated (2.6 million)
[79], we needed to narrow the scope of potential venues to
reduce redundancy and increase study efficiency.
To select specific venues for sampling during the study’s
planning phase, we drew on Department of Urban
Planning geographic data showing the location, land use
(residential vs. commercial), and other attributes of every
building in Brooklyn [80]. With this, we defined a “venue”
as any city block within the core HRA with >70 %
commercial land use. Study staff then reviewed a random
sample from this sampling frame to qualitatively assess
whether this approach would yield sufficient foot traffic for
study recruitment. To supplement this block approach, we
also included public parks and public housing projects as
discrete venues for sampling.
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venue. VDTs were defined as four-hour blocks where a
sufficient number of the target population passes
through the venue. For each venue defined above, we in-
cluded a morning, afternoon, and evening VDT for po-
tential recruitment. This ultimately yielded a sampling
frame of 394 block venues and 75 park and housing pro-
ject venues available for random selection during the
study, each with 3 associated time periods.Sampling VDTs
On a monthly basis, after excluding dates for holidays
and related events, a sample is drawn from the sampling
frame based on the number of planned recruitment
events per month. This involves a two-stage sampling
process: first a simple random sample of venues, then
for each sampled venue, a random sample of associated
time blocks. Sampling is done without replacement for
each month, but previously selected VDTs are eligible
for sampling in subsequent months. For each selected
VDT, we also sample two alternate VDTs in the event
that recruitment within the main VDT is infeasible due
to safety concerns or low attendance. One week prior to
the recruitment event, study staff members observe the
selected venue to determine its suitability with respect
to safety and other logistical concerns. Study staff also
secures a location to conduct confidential study activ-
ities, or used a large mobile van. We will conduct up to
4 VBS events per month over 30 months for a total sam-
ple size of 400 participants enrolled.Eligibility criteria
The VBS eligibility criteria are the same as in the PDI/
RDS study described above, with the following excep-
tions: VBS participants must reside in the core HRA
(not the larger HRA), and those with previously diag-
nosed HIV are ineligible. Thus, the VBS eligibility cri-
teria are: aged 18-60 years; sexually active (vaginal and/
or anal sex) with at least one opposite sex partner within
the previous year; reside in the core HRA’s seven zip
codes; African American/Black or Latino/Hispanic race/
ethnicity; comprehend English or Spanish; unknown or
negative HIV status; not actively psychotic based on
valid screening instrument.Primary outcome measure
The primary outcome is the yield and efficiency of VBS to
identify undiagnosed HIV infection among HHR, which
will be compared to rates in the RDS sample. HIV status is
assessed with the OraQuick Advance Rapid HIV-1/2 Anti-
body Test using oral fluid and OraSure Western Blot for
confirmatory testing using oral mucosal fluids.Description of study activities
Enrollment targets The goal is to enroll 6 to 9 partici-
pants at each event. The field team is comprised of a
supervisor, a HIV test counselor/interventionist (who
deliver HIV test results), and 2-3 Research Associates. At
least one staff member at every event is a trained phlebot-
omist. Team members include both males and females
from diverse socio-economic and racial backgrounds who
are knowledgeable about, comfortable with, and experi-
enced with the local area, target population, and field re-
cruitment methods. As in the BCAP PDI, the overarching
counseling approach is Motivational Interviewing [46].
At the enrollment event, participants who cross a pre-
specified recruitment line in the selected venue are
approached by a staff member and recruited for the screen-
ing interview. All those who cross this line are counted to
enumerate the venue size. Individuals who cross the line
are asked if they would be willing to participate in a brief
(15 min) health screening interview for a community health
study, depending on staff availability. We estimate 50-75 %
of participants who cross the line will be approached.
A brief screening interview determines study eligibility.
Those who consent to participate but who are unable to
complete the study activities at that time may complete
activities at the study field site location within two weeks
of recruitment.
Participants then engage in HIV pre-test counseling
and receive a rapid OraQuick HIV test. During the
20-min processing period, the participant completes a
structured baseline interview using ACASI, which mea-
sures socio-demographic and background factors, health,
substance use, sexual behavior, and HIV testing history
using a battery of measures collected across all NIDA
STTR projects [81–83].
Participants with a non-reactive (negative) test result
receive risk reduction counseling. Those with reactive test
results are informed about the preliminarily positive result,
and the need for confirmatory testing. A confirmatory test
is conducted, and the interventionist initiates a brief discus-
sion about this new diagnosis, individually tailored in light
of the wide variety of participant reactions to HIV diagnoses
[84]. Then the interventionist discusses the need for HIV
primary care and makes an appointment for HIV primary
care at a setting the participant finds convenient and accept-
able. Third, the interventionist informs the participant that
all those who test preliminarily positive are asked to give
blood specimens, in order to document the initial health sta-
tus of those with new diagnoses. In the final component of
the post-test counseling session, participants are provided
with the interventionist’s contact information, for support,
referrals, or any other concerns and are scheduled for a
return appointment for the confirmatory test result at the
project field site two-weeks later. Participants receive com-
pensation at an equivalent rate to the PDI/RDS study.
Gwadz et al. BMC Public Health  (2015) 15:481 Page 12 of 14Power analysis
For the Seek and Test study aim, 3000 HHR recruited by
RDS are compared with 400 HHR recruited by VBS on
the outcome of newly diagnosed HIV infection. Assuming
10 % of the RDS sample will have newly identified HIV in-
fection, the study is powered to detect a difference in seek
approaches of OR = 1.79 with 80 % power (α = .05). If the
intraclass correlation (ICC) for previously undiagnosed
HIV infection is as high as .20 (due to clustering of indi-
viduals within 80 recruitment chains), the effective sample
size is as low as n = 361 in the RDS group, and OR = 2.25
is detected with 80 % power (α = .05).
Analysis plan
We will examine differences in demographic characteris-
tics between VBS and RDS participants and adjust for
these when comparing VBS and RDS. The guiding hy-
pothesis for the Seek and Test aim is the following: com-
pared with VBS, and controlling for potential differences
on key socio-demographic characteristics across the sam-
ples, participants recruited by RDS will be more likely to
be newly diagnosed with HIV. This hypothesis is assessed
using logistic regression analysis. Newly diagnosed HIV
infection (Yes/No) is regressed on a dummy variable
created to contrast participants recruited at venues with
participants recruited by RDS. If the coefficient for this
variable is positive and significant, we will conclude that
RDS is a more effective approach for seeking HHR likely
to have undiagnosed HIV infection. Covariates will in-
clude prior HIV testing.
Discussion
The present study seeks to examine two approaches to
uncovering undiagnosed HIV infection in an under-
studied population: heterosexuals at high risk for HIV.
Further, it tests components to link those with HIV-
infection to HIV primary care with high retention, both
newly diagnosed and those with previous HIV diagnoses.
Study results will provide guidance on the most efficient
and cost-effective means of uncovering this largely hid-
den and vulnerable population (by comparing RDS vs.
VBS), and to link HIV-infected individuals to HIV care
(by comparing the PDI arm vs. control). The ultimate
aim of the present study is to provide an efficient, cost-
effective, reproducible, and scalable sampling method
and intervention approach to address the critical public
health problem of undiagnosed HIV infection and delays
in engagement in HIV care among HHR. This protocol
provides background for other investigators interested in
researching this population, which is challenging to
define, reach, and engage.
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